Back
Vanguard Dividend Appreciation ETF Vs. Summit Therapeutics Industry Stock Comparison
Buy
72
VIG
Vanguard Dividend Appreciation ETF
Last Price:
195.78
Seasonality Move:
1.91%
Buy
75
SMMT
Summit Therapeutics
Last Price:
24.55
Seasonality Move:
26.72%
Buy
72
Vanguard Dividend Appreciation ETF (VIG)
is a Buy
Is Vanguard Dividend Appreciation ETF a Buy, Sell or Hold?
- The current Vanguard Dividend Appreciation ETF [VIG] share price is $195.80. The Score for VIG is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
- VIG is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
75
Summit Therapeutics (SMMT)
is a Buy
Is Summit Therapeutics a Buy, Sell or Hold?
- The current Summit Therapeutics [SMMT] share price is $24.55. The Score for SMMT is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
- SMMT is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
VIG Stock Price Chart
What is Vanguard Dividend Appreciation ETF's stock price today?
-
The Vanguard Dividend Appreciation ETF share price today is $195.80
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VIG is experiencing selling pressure, which indicates risk of future bearish movement.
SMMT Stock Price Chart
What is Summit Therapeutics's stock price today?
-
The Summit Therapeutics share price today is $24.55
The current trend is moderately bullish and SMMT is experiencing selling pressure, which indicates risk of future bearish movement.
VIG Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.73 | Buy |
Relative Strength Index (14 RSI): | 61.29 | Buy |
Chaikin Money Flow: | -575343 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (191.26 - 195.3) | Buy |
Bollinger Bands (100): | (180.35 - 191.23) | Buy |
SMMT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 4.26 | Buy |
Relative Strength Index (14 RSI): | 64.67 | Buy |
Chaikin Money Flow: | -4213296 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (10.3 - 23.18) | Buy |
Bollinger Bands (100): | (4.28 - 15.36) | Buy |
VIG Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 194.78 | Buy |
20-day SMA: | 193.93 | Buy |
50-day SMA: | 190.07 | Buy |
200-day SMA: | 180.13 | Buy |
8-day EMA: | 195.12 | Buy |
20-day EMA: | 193.54 | Buy |
50-day EMA: | 190.41 | Buy |
200-day EMA: | 180.51 | Buy |
SMMT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 25.55 | Sell |
20-day SMA: | 17.97 | Buy |
50-day SMA: | 13.36 | Buy |
200-day SMA: | 6.72 | Buy |
8-day EMA: | 24.49 | Buy |
20-day EMA: | 19.78 | Buy |
50-day EMA: | 14.83 | Buy |
200-day EMA: | 8.2 | Buy |
Vanguard Dividend Appreciation ETF Earnings Growth & VIG Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Summit Therapeutics Earnings Growth & SMMT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.01 per share, an increase this year of $0.32 per share, and a decrease next year of $0.03 per share.
Vanguard Dividend Appreciation ETF Technical Analysis
Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Summit Therapeutics Technical Analysis
Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |